Andrew Reardon

CIK: 0001950232

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)64 (70.3%)

Position reduction

Option Exercises (M)8 (8.8%)

Derivative conversions

Awards (A)6 (6.6%)

Compensation grants

Other (G, F, J, C, D, …)13 (14.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

LGND

LIGAND PHARMACEUTICALS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (91 total)

LGND
LIGAND PHARMACEUTICALS INC
Oct 2, 2026
Sale(S)
Direct
1.5K shares at avg. $304.52$467K
LGND
LIGAND PHARMACEUTICALS INC
Oct 2, 2026
Sale(S)
Direct
17 shares at avg. $307.74$5K
LGND
LIGAND PHARMACEUTICALS INC
Oct 2, 2026
Sale(S)
Direct
235 shares at avg. $307.19$72K
LGND
LIGAND PHARMACEUTICALS INC
Oct 2, 2026
Sale(S)
Direct
404 shares at avg. $306.18$124K
LGND
LIGAND PHARMACEUTICALS INC
Oct 2, 2026
Sale(S)
Direct
833 shares at avg. $302.51$252K
LGND
LIGAND PHARMACEUTICALS INC
Oct 2, 2026
Exercise(M)
Direct
340 shares at avg. $52.27$18K
LGND
LIGAND PHARMACEUTICALS INC
Oct 2, 2026
Sale(S)
Direct
2K shares at avg. $303.54$600K
LGND
LIGAND PHARMACEUTICALS INC
Sep 3, 2026
Sale(S)
Direct
400 shares at avg. $288.98$116K
LGND
LIGAND PHARMACEUTICALS INC
Sep 3, 2026
Sale(S)
Direct
1.8K shares at avg. $285.17$513K
LGND
LIGAND PHARMACEUTICALS INC
Sep 3, 2026
Sale(S)
Direct
300 shares at avg. $283.99$85K
LGND
LIGAND PHARMACEUTICALS INC
Sep 3, 2026
Sale(S)
Direct
385 shares at avg. $287.53$111K
LGND
LIGAND PHARMACEUTICALS INC
Sep 3, 2026
Sale(S)
Direct
2.1K shares at avg. $286.36$606K
LGND
LIGAND PHARMACEUTICALS INC
Aug 3, 2026
Sale(S)
Direct
1.2K shares at avg. $287.77$349K
LGND
LIGAND PHARMACEUTICALS INC
Aug 3, 2026
Sale(S)
Direct
356 shares at avg. $288.75$103K
LGND
LIGAND PHARMACEUTICALS INC
Aug 3, 2026
Sale(S)
Direct
503 shares at avg. $289.80$146K
LGND
LIGAND PHARMACEUTICALS INC
Aug 3, 2026
Sale(S)
Direct
1K shares at avg. $286.80$296K
LGND
LIGAND PHARMACEUTICALS INC
Aug 3, 2026
Sale(S)
Direct
991 shares at avg. $291.71$289K
LGND
LIGAND PHARMACEUTICALS INC
Aug 3, 2026
Sale(S)
Direct
409 shares at avg. $292.82$120K
LGND
LIGAND PHARMACEUTICALS INC
Aug 3, 2026
Exercise(M)
Direct
5K shares at avg. $52.27$261K
LGND
LIGAND PHARMACEUTICALS INC
Aug 3, 2026
Sale(S)
Direct
105 shares at avg. $284.14$30K
LGND
LIGAND PHARMACEUTICALS INC
Aug 3, 2026
Sale(S)
Direct
33 shares at avg. $284.55$9K
LGND
LIGAND PHARMACEUTICALS INC
Aug 3, 2026
Sale(S)
Direct
157 shares at avg. $285.74$45K
LGND
LIGAND PHARMACEUTICALS INC
Aug 3, 2026
Sale(S)
Direct
200 shares at avg. $290.60$58K
LGND
LIGAND PHARMACEUTICALS INC
Jul 1, 2026
Sale(S)
Direct
100 shares at avg. $314.58$31K
LGND
LIGAND PHARMACEUTICALS INC
Jul 1, 2026
Sale(S)
Direct
900 shares at avg. $315.78$284K

		Type	Shares	Price		Ownership
Oct 2, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	1,535	$304.52	$467,431	Direct
Oct 2, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	17	$307.74	$5,232	Direct
Oct 2, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	235	$307.19	$72,190	Direct
Oct 2, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	404	$306.18	$123,698	Direct
Oct 2, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	833	$302.51	$251,991	Direct
Oct 2, 2026	LGND LIGAND PHARMACEUTICALS INC	Exercise(M)	340	$52.27	$17,772	Direct
Oct 2, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	1,976	$303.54	$599,804	Direct
Sep 3, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	400	$288.98	$115,592	Direct
Sep 3, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	1,800	$285.17	$513,301	Direct
Sep 3, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	300	$283.99	$85,196	Direct
Sep 3, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	385	$287.53	$110,697	Direct
Sep 3, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	2,115	$286.36	$605,649	Direct
Aug 3, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	1,214	$287.77	$349,357	Direct
Aug 3, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	356	$288.75	$102,795	Direct
Aug 3, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	503	$289.80	$145,771	Direct
Aug 3, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	1,032	$286.80	$295,974	Direct
Aug 3, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	991	$291.71	$289,086	Direct
Aug 3, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	409	$292.82	$119,763	Direct
Aug 3, 2026	LGND LIGAND PHARMACEUTICALS INC	Exercise(M)	5,000	$52.27	$261,350	Direct
Aug 3, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	105	$284.14	$29,834	Direct
Aug 3, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	33	$284.55	$9,390	Direct
Aug 3, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	157	$285.74	$44,861	Direct
Aug 3, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	200	$290.60	$58,120	Direct
Jul 1, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	100	$314.58	$31,458	Direct
Jul 1, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	900	$315.78	$284,200	Direct

1-25 of 91 transactions

About Reardon Andrew

Reardon Andrew (SEC CIK 0001950232) files insider reports with the SEC as CLO & Secretary of LIGAND PHARMACEUTICALS INC (LGND).

Signal8 holds 18 ownership filings by Reardon Andrew, all Form 4s, filed between Sep 25, 2024 and Oct 6, 2026. Those filings report 91 transactions, from Aug 10, 2024 to Oct 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Reardon Andrew's filings is in JUPITER, FL.

Recent filings by Reardon Andrew

Oct 2, 2026: Open-market sales of LGND shares (5 lines, Form 4, code S).
Oct 2, 2026: Option exercise of LGND shares (Form 4, code M).
Oct 2, 2026: Open-market sale of LGND shares (Form 4, code S).
Sep 3, 2026: Open-market sales of LGND shares (5 lines, Form 4, code S).
Aug 3, 2026: Open-market sales of LGND shares (6 lines, Form 4, code S).

Other insiders filing for LIGAND PHARMACEUTICALS INC (LGND)

Aryeh Jason, Director
Zimmermann Martine, Director
Espinoza Octavio, Chief Financial Officer
Haas Jason, Director
Davis Todd C, Chief Executive Officer
Sabba Stephen L, Director

How to read Form 4 transaction codes